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ABSTRACT
Introduction Child maltreatment involves acts of omission 
(neglect) or commission (abuse) often by caregivers that 
results in potential or actual harm to a child. The Building 
Blocks trial (ISRCTN23019866) assessed the short-term 
impact of an intensive programme of antenatal and 
postnatal visiting by specially trained nurses to support 
young pregnant women in England. The Building Blocks: 
2–6 Study will assess the medium-term impacts of the 
programme for mothers and children (n=1562), through 
the linkage of routinely collected data to the trial data, 
with a particular emphasis on the programme’s impact on 
preventing child maltreatment.
Methods and analysis We have developed a bespoke 
model of data linkage whereby outcome data for the 
trial cohort will be retrieved by linked anonymous 
data abstraction from NHS Digital, Office for National 
Statistics and the Department for Education’s National 
Pupil Database. Participants will be given reasonable 
opportunity to opt out of this study prior to data transfer. 
The information centres will match participants to the 
information held in their databases using standard 
identifiers and send extracts to a third-party safe haven. 
The study will have 80% power to detect a 4% difference 
(4%vs8%) for the binary primary outcome of child in 
need status (from birth to key stage 1) at a two-sided 
5% alpha level by following up 602 children in each trial 
arm. Analysis will be by intention to treat using logistic 
multilevel modelling. A cost-and-consequences analysis 
will extend the time frame of the economic analysis from 
the original trial.
Ethics and dissemination The study protocol has been 
approved by the National Health Service Wales Research 
Ethics Committee and the Health Research Authority’s 
Confidentiality Advisory Group. Methods of innovative 
study design and findings will be disseminated through 
peer-reviewed journals and conferences; results will be of 
interest to clinical and policy stakeholders in the UK.
Trial registration number ISRCTN23019866.
IntroductIon
Maltreatment
Child maltreatment involves acts of omission 
(neglect) or commission (abuse) often by 
caregivers who inflict harm or fail to act to 
prevent harm to a child.1 Abuse may be phys-
ical, emotional or sexual. Neglect represents 
persistent failure to meet basic physical or 
psychological needs, often resulting in serious 
impairment of the child’s health and/or 
development.1 Neglect may involve failing to 
protect a child from physical and emotional 
harm or danger, provide adequate supervision 
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Protocol
Strengths and limitations of this study
 ► This study aims to provide much-needed evidence 
about the medium-term benefits of the Family 
Nurse Partnership programme in England. This 
study has the capacity to either confirm the current 
perspective on the value of the intervention or 
demonstrate clinically meaningful benefits to 
children in vulnerable young families
 ► There are distinct benefits associated with using 
routine data including a reduction in cost and 
participant burden over prospectively collected 
data and relative completeness and therefore 
minimisation of bias over self-report, particularly for 
such sensitive outcomes
 ► The establishment of a regulatory secure research 
database for this cohort of trial participants also 
offers the prospect of further data being added over 
the longer term and of broadening the scope of the 
dataset to other outcome domains relevant to this 
intervention, such as criminal justice and welfare 
benefits
 ► The extent of this benefit will be balanced by 
our ability to adequately access the data from 
information centres in a timely fashion, the quality 
of matching conducted as well as the quality of the 
data ultimately retrieved
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or ensure access to appropriate medical care. In the year 
ending 31 March 2015 in England, there were 635 600 
referrals to children’s social care (CSC) services, 403 400 
children starting an episode of need (an overall rate of 
348.0 per 10 000) and 62 200 children became subject of 
a child protection plan.2 Of children who became subject 
of a child protection plan, the most common initial cate-
gory of abuse was neglect (43.2%) followed by emotional 
abuse (33.7%).
In the UK, preventing maltreatment is an important 
focus of government concern. The Children Act 1989 
specifies agencies’ responsibilities to cooperate in the 
interests of vulnerable children, for children in need 
(section 17) and children suffering or likely to suffer 
from significant harm (section 47). A child in need (CIN) 
is defined as a child who is unlikely to achieve or main-
tain a reasonable level of health or development or whose 
health and development is likely to be significantly or 
further impaired, without the provision of services or is 
a child who is disabled. Local authority provisions may 
include supervision of activities, financial help, provision 
of family accommodation, respite or home help in addi-
tion to advice and guidance from social workers.
Family nurse Partnership home-visiting programme
There has been increasing emphasis on the primary 
prevention of child maltreatment, including interven-
tions directed at general populations and those targeting 
high-risk groups.3 One such intervention is the Family 
Nurse Partnership (FNP) programme (developed in 
the USA as the Nurse Family Partnership (NFP))—a 
home-visiting approach with three overarching goals: to 
improve birth outcomes, optimise child health and devel-
opment including reducing maltreatment, and promote 
economic self-sufficiency of mothers.4
In three US trials (in Elmira, Memphis and Denver),5–7 
the NFP has demonstrated improvements in prenatal 
health behaviours and birth outcomes, sensitive child 
care, maternal life course (eg, greater workforce partici-
pation) and child and adolescent functioning. It has also 
shown positive effects in relation to reductions in rates 
of child injuries, abuse and neglect. In the first US trial 
in 1977, a subgroup analysis of poor unmarried teens 
(54 families) revealed that, by age 2, there was verified 
abuse/neglect in 19% of control children compared with 
4% in the group in receipt of NFP in both pregnancy and 
infancy (treatment difference of 0.15, 95% CI of −0.01 to 
0.31) and 56% relative reduction in emergency depart-
ment encounters for injuries and ingestions during the 
second year of life.5 Among the subgroup of children (56 
families) with a state-verified report of maltreatment by 
age 4, the NFP group of children exhibited fewer risks 
for harm than the control group (eg, fewer attendances 
with injuries/ingestions, safer home environment) 
at follow-up points between 25 and 50 months of life.8 
This was considered to be due to the earlier and more 
comprehensive detection of maltreatment by nurse-vis-
ited families.
The NFP programme was adapted for implementation 
as the FNP and was introduced in England in 2007. Our 
Building Blocks trial (ISRCTN23019866) was the first trial 
of FNP in England and evaluated short-term outcomes 
to age 2—the duration of the FNP programme.9 The 
trial reported no difference for four primary outcomes: 
biomarker-calibrated self-reported tobacco use by the 
mother at late pregnancy, birth weight of the baby, the 
proportion of women with a second pregnancy within 
24 months postpartum and emergency attendances and 
hospital admissions for the child within 24 months post-
partum.10 We observed some differences for secondary 
child development outcomes including the rate of safe-
guarding events reported in primary care records. While 
the current evidence does not support continuation of 
the programme in England, previous evaluations have 
demonstrated benefit over the longer term (eg, up to 15 
years of age).11 For maltreatment outcomes, this benefit 
has been increasingly evident after the age of 4 years;12 
therefore, the current study will establish whether FNP 
has moderated maltreatment outcomes over a medi-
um-term period of follow-up (ie, to the point where the 
child is aged 6 years old).
Methods and analysIs
research objective
The Building Blocks: 2–6 Study (BB:2-6) will use data 
linkage of routinely collected national datasets to assess 
the medium-term impact of the FNP intervention on child 
maltreatment outcomes and key indicators of neglect.
study design
This is a data linkage study, which will generate a linked 
anonymised database hosted by an independent trusted 
third party. Participant mothers and children from 
Building Blocks: 0–2 (BB:0–2) will be followed up for a 
further 4 years using routine data only. Data from various 
routine public sector sources will be retrieved and linked 
to the trial data to enable children and mothers to be 
followed until the child reaches key stage 1 (the 2 years 
of schooling when pupils are aged between 5 and 7). The 
study formally started in February 2014 and will report 
to the funder in May 2018. Participants were recruited to 
the trial between June 2009 and July 2010 and the 6-year 
follow-up ends (ie, the last child will have turned 6) in 
March 2017. A summary of the data sources is provided 
in table 1, and the time period for each dataset is shown 
in figure 1 . Study outcomes are summarised in table 2.
data providers and datasets
The BB:0–2 trial data
Data collected for the initial trial will be used in the present 
study.9 10 A baseline home assessment was conducted on 
trial entry using computer-assisted personal interview 
(CAPI). Follow-up was by computer-assisted telephone 
interview at 34–36 weeks gestation and 6, 12 and 18 months 
postnatal. A final home-based CAPI was conducted at 2 
years after birth. Several routinely collected datasets were 
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Figure 1 Follow-up and datasets over the six years.  A&E, accident and emergency; PRU, pupil referral unit.
Table 2 Study outcomes
Domains Outcomes HES ONS NPD
Primary:
CIN status recorded at any time during the 
follow-up period
CIN status as of 31 March each year ✓
Secondary:
(1) Objective measures of maltreatment Child protection registration ✓
Details of a child protection plan ✓
CIN categorisation ✓
CIN duration ✓
Looked after status ✓
CLA period of care ✓
Legal status of CLA ✓
Cause of death ✓
(2) Associated measures of maltreatment DNA appointments ✓
Injuries and ingestions ✓
(3) Intermediate FNP programme outcomes Subsequent pregnancies ✓
(4) Costs Health and social care resource use ✓ ✓
(5) Child health, developmental and 
educational outcomes
Special educational needs ✓
Disability ✓ ✓
Day care attendance ✓
Early-years assessment ✓
School attendance ✓
Key stage 1 attainment ✓
CIN, child in need; CLA, child looked after; DNA, did not attend; FNP, Family Nurse Partnership; HES, Hospital Episode Statistics; NPD, 
National Pupil Database; ONS, Office for National Statistics.
accessed, and data were obtained from the following 
sources: maternity records (medical and obstetric history 
items, antenatal attendances and maternal and neonatal 
outcomes), primary care notes for each mother and child 
dyad (consultations, immunisations, pregnancies, safe-
guarding), abortions data from the Department of Health 
(DoH) abortions statistics team and immunisation data via 
Cover of Vaccination Evaluated Rapidly contacts.
NHS Digital
The Hospital Episode Statistics (HES) datasets hold 
records on over 125 million hospital admissions, outpa-
tient and accident and emergency episodes each year. 
Data can be requested from NHS Digital (formerly 
known as the Health and Social Care Information 
Centre), the executive non-departmental public body 
established under the Health and Social Care Act 
2012.13 All available records belonging to cohort 
members (mothers and children) will be obtained from 
study entry of the mother, which occurred between 
 o
n
 29 June 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2016-015728 on 13 July 2017. Downloaded from 
 5Lugg-Widger FV, et al. BMJ Open 2017;7:e015728. doi:10.1136/bmjopen-2016-015728
Open Access
June 2009 and July 2010 until the date the child turns 
6. The data requested include diagnoses, procedures, 
length of episode and external causes of injuries coded 
according to the 10th revision of the International 
Statistical Classification of Diseases and Related Health 
Problems (ICD-10) codes.14
NHS Digital has responsibility for collecting these data 
from across the health and social care system to allow NHS 
hospitals to be paid for the care they deliver. At the end of 
the financial year (March), a final dataset is collated. This 
dataset is cleaned and validated before being available for 
research at the end of the year (December).
Office for National Statistics
The Office for National Statistics (ONS) collects 
information on cause of death from civil registration 
records. Mortality data can be accessed through NHS 
Digital. For registered deaths, the underlying cause 
of death is derived from the sequence of conditions 
leading directly to the death and is recorded on the 
death certificate. Deaths are subsequently coded in line 
with the ICD-10.
Department for Education
The Department for Education (DfE) holds information 
on pupils throughout the different phases of education. 
Records are sourced from publicly funded schools, local 
authorities and awarding bodies and held in the National 
Pupil Database (NPD). Datasets are available on various 
aspects of education such as School Census data, absence 
data and school attainment.15 All available records for the 
children in the cohort will be obtained from the various 
datasets held. Data coverage will vary depending on the 
dataset in question. For example, the School Census 
returns data on maintained schools (funding and over-
sight is through the local authority), which represents 
the majority of schools, academies (funding and over-
sight is from DfE), city technology colleges, maintained 
and non-maintained special schools and hospital special 
schools. Schools that are entirely privately funded 
and home education are not included in the data; this 
represents 7% of English students.16
In the UK, education is mandatory from the first school 
term after their fifth birthday. Prior to this, some chil-
dren may not have received formal early-years provision 
and therefore may not appear in the datasets. A survey 
conducted in 2014–2015 commissioned by DfE reported 
that 25% of children aged 0–4 were not in receipt of any 
early-years provision. Older preschool children (aged 
3–4), however, were far more likely to receive early-years 
provision (92%) than younger preschool children (aged 
0–2) (61%).17 We would therefore expect similar coverage 
rates for this study.
The data requested include the number of hours 
attended, early educational development, eligibility for 
free school meals and special educational needs provision 
type. Datasets are collated throughout the year and are 
available at set time points annually.
Social care data
Social care data from local authorities are available 
through the NPD via two datasets, CIN and child looked 
after (CLA). The CIN census captures individual level 
information on children referred to and assessed by chil-
dren’s social care services within each 12-month period.18 
CLA is collected in the SSDA903 return, an annual statu-
tory data collection for all local authorities.19 Any child in 
the cohort who is in one of these datasets will be identified. 
Mothers who were <18 years at the time of participation 
in the BB:0–2 trial will also be identified in these datasets. 
There will not be the coverage issues as seen in the educa-
tion data returns, and importantly, the primary outcome 
will be sourced from these social care datasets.
study participants: inclusion and exclusion criteria
Eligible participants are those mothers recruited to the 
BB:0–2 trial and their first child (or twins, if relevant) 
and who were not mandatorily withdrawn from the study 
or electively withdrew including their consent for use of 
their data. Women were recruited as nulliparous women 
aged 19 or under, living in one of 18 local authority FNP 
catchment areas; recruited by 24+6 weeks gestation, have 
conversational level of English and were able to consent 
to research.10
Children in medium-term foster placements or adopted 
within the 6-year study period can be linked up to the date 
of adoption. Maternal or child death will be captured as 
an outcome.
recruitment/dissent
Participants previously consented to enter into the BB:0–2 
trial and provide self-report and access to their routine 
records for the period up to 2 years post partum. In order 
to obtain an unbiased estimate of the medium-term 
effect of FNP on objective and associated maltreatment 
outcomes, we have received section 251 (s251) support 
of the 2006 NHS Act approval from the Health Research 
Authority’s Confidentiality Advisory Group (HRA CAG) 
to pass identifiable participant data legally held by Cardiff 
University to the information centres (ICs) to link to 
routine data. This is without obtaining further consent 
from participants, instead using an opt-out/dissent 
model.
Justification of approach
Consent for longer-term follow-up (ie, beyond 24 months 
post partum) was originally proposed in the BB:0–2 trial. 
However, on ethical review, it was considered that greater 
specificity about exact outcomes than could be provided 
at recruitment was required. Additionally, providing 
meaningful consent for much longer follow-up was also 
challenging, particularly on behalf of yet-to-be-born chil-
dren.
Developing the opt-out approach was necessary due to 
(1) the child protection focus of the study and the conse-
quent sensitivity and impracticality in asking directly 
for consent, (2) the mobility and relative difficulty in 
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Figure 2 Governance and information centre requirements prior to application approval. s251, section 251 of the NHS 2006 
Act; ONS, Office for National Statistics; NPD, National Pupil Database; IG Information Governance. 
ongoing direct access to these participants, (3) the 
consequent introduction of non-ascertainment bias on 
sample representativeness—resulting in a non-random 
sample—and (4) the likely cost and logistical require-
ments of securing even modest levels of additional 
consent.
Methods of notifying participants
We discussed the issue of dissent and fair processing 
with the HRA CAG and have subsequently attempted to 
contact all mothers recruited to the original BB:0–2 trial 
to inform them that medium-term follow-up using anony-
mised records will be undertaken.
Details of participants’ residential addresses were 
updated using their most recent address registered 
with their general practitioner. Where available, mobile 
number and email addresses collected for the trial were 
used to send SMS and emails to participants. All three 
modes of contact were used over a 2-day period, and 
participants were provided with a 2-month window in 
which to contact the project team to discuss the project 
and opt-out if they wished. A website was also available 
with the same information, which directed participants to 
contact the project team if they wished.
Development of opt-out letter
A group of care-experienced young people (CASCADE 
Voices)20 advised on the layout, wording and tone of a 
letter to be sent to all participants. A key consideration 
was to communicate the focus of this follow-on study in 
a sensitive manner. The final letter was approved by both 
an NHS Research Ethics Committee and CAG committee 
as part of overall governance approval for the study. The 
letter contained information on the trial, the follow-on 
study and a flowchart for what to do if women wished to 
discuss the project and/or opt out.
Process to manage dissent
Women notifying the study team of their dissent will be 
recorded as ‘opted out,’ removed from all project datasets 
for this follow-up work, and identifiable datasets are to be 
sent to ICs. They will not be included in any of the data-
sets or analyses for this follow-on study.
Governance and compliance
Following ethical approval (14/WA10062) and s251 
support (CAG 10-08(b)/2014), data request applications 
were submitted to DfE, NHS Digital and ONS.
In order to satisfy the requirements of the s251 support 
and NHS Digital contract, the Information Governance 
(IG) Toolkit self-assessment21 (commissioned by the 
Department for Health for NHS Digital to develop and 
maintain) was required. This organisation-level assess-
ment provides reassurance of satisfactory information 
governance within the host trials unit. Both the s251 
support and IG Toolkit are assessed and renewed on 
an annual basis. The opt-out model was also required 
to satisfy s251 support as well as the DfE assessment of 
compliance with principle 1 of the Data Protection Act 
1998. Governance and IC requirements prior to applica-
tion approval are shown in figure 2 .
data matching
Maternal and child identifiers will be sent to both NHS 
Digital and DfE for matching with their databases. Each 
IC holds differing identifiers including a unique iden-
tifier for each individual (NHS number; unique pupil 
number (UPN)).
Matching with HES data will be by exact matching on 
NHS number, date of birth, postcode and gender. This 
was conducted for BB:0–2 and achieved a high match 
rate where 99.6% of mothers’ and babies’ records were 
matched fully (ie, matched on all identifiers provided) 
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Figure 3 Data flow. (1) Participant identifiable information securely transferred for linkage. (2) De- identification and 
standardisation applied (eg, date of birth to week of birth). (3) Information centres confirm matching of participant identifiers. 
(4) Hosted on SAIL secure platform. ALF, anonymous linking field; BB:0-2, the Building Blocks trial; DfE, Department for 
Education; DPO, data-providing organisation; HES, Hospital Episode Statistics; ONS, Office for National Statistics; SAIL, Secure 
Anonymised Information Linkage. 
or partially (ie, matched on a reduced but acceptable 
number of identifiers provided). This will be repeated for 
this study. NHS Digital will then exact match with ONS 
using NHS number in order to obtain mortality data.
As NPD does not include NHS numbers, initially, exact 
matching on first name and surname, date of birth and 
postcode (of both mother and child for social care data; 
all other datasets, just child) will be undertaken. Further 
matching required will be by fuzzy matching of first name. 
The CIN and CLA datasets do not contain names or post-
codes. Therefore the matching will be in two phases: (1) 
participants will be matched with NPD, and UPN will be 
added to all participants and (2) this will be used to iden-
tify individuals in the CIN and CLA datasets.
Data matching at DfE and NHS Digital/ONS are inde-
pendent; therefore, match rates at the participant level are 
expected to vary (some may match to NPD but not HES). 
Educational records should be available for all children 
in the trial cohort, whereas health and social care derived 
data will only exist where the child has received a relevant 
episode of care. Participants will be compared using trial 
baseline data to check for any bias between those who are 
matched and not matched for those datasets where they 
would all be expected to be present (eg, School Census 
for all children).
Pseudonymised dataset
A unique study ID will be attached to each participant’s 
record prior to data transfer to ICs. Once ICs have 
matched records to their database, only the unique study 
ID is retained. Data extracts from both ICs plus data files 
from the trial (following a process of de-identification and 
standardisation in Cardiff to reduce risk of later uninten-
tional participant level identification) will all be securely 
transferred to a data safe haven,22 the Secure Anonymised 
Information Linkage (SAIL) databank, for linking and 
storage. The data flow is shown in figure 3.
A SAIL data analyst will reassign the study ID with a 
new anonymous linking field (ALF) and store the corre-
sponding ID in a separate encrypted password-protected 
file.23
Participants will not be identifiable to the study team or 
to the SAIL analyst, but incoming datasets can be linked 
at the individual level using the ALF. The study team 
will have controlled remote access to these data, thus 
ensuring the security of the pseudonymised database.24 
All data cleaning and analysis will be carried out via the 
remote portal by the study data manager and statistician.
Data from NHS Digital and NPD will be requested at 
two time points. The first data extract will confirm the 
data flow model and assess data quality and the suitability 
of data for answering key study analyses. The second data 
request will be made once all children in the study have 
reached key stage 1 (April 2017) and on which the study 
findings will be reported on (2018).
Control of data
Cardiff University controls under contract the identifi-
able trial data that are being transferred to the ICs and 
to the safe haven. Data held by NHS Digital, ONS and 
DfE, for which they are the controllers, are de-identified 
and then sent to SAIL to be linked and held (including 
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the de-identified trial data) in a secure anonymised 
standalone database for use by nominated study team 
members. SAIL will control the safe haven environment 
and will process the pseudonymised data for secure 
use by study team. Cardiff University will control the 
purposes to which the data are put in answering research 
questions as per the study protocol. Once linked in the 
data safe haven, the ability to submit queries to each 
IC about individual records will be more limited than 
if identifiable data were returned to the research team 
in Cardiff. Data cleaning will remain possible, however, 
as will generic queries about data provided in batch. 
The quality of matching conducted by NPD and NHS 
Digital/ONS will be a key factor in the success of the 
study.
analysis
Power calculation
Primary outcome (CIN status at any point between birth 
and 6 years): for CIN status, available UK data on rates are 
not specific to the age range of interest, but the rate in 
the general population aged 5–9 years is 4.6% (for local 
authorities comprising study sites in BB:0–2). The rate of 
CIN status would be expected to be greater in the specific 
study sample, and therefore, we have assumed a rate of 
8%. We hypothesise that FNP would reduce the detection 
of CIN in the first 6 years and thus assumed a difference 
of 4% as being important. To detect a difference of 4% 
(FNP of 4% vs usual care of 8%) would require 602 chil-
dren in each arm (1204 in total) using 80% power and a 
two-sided 5% alpha level.
BB:0–2 recruited 1645 women, with 1562 available 
for follow-up (ie, excluding those subject to a manda-
tory withdrawal). Follow-up through medical records 
(assuming 10% loss in tracking and linkage) would result 
in 1405 participants, thus securing enough data to test 
the primary outcome.
Main analysis
Analyses will be conducted on an intention-to-treat basis 
and due emphasis placed on CIs for the between-arm 
comparisons. Descriptive statistics of demographic and 
baseline measures will be used to ascertain any marked 
imbalance between the trial arms. The primary compara-
tive analysis on CIN status at any point between birth and 
6 years will use logistic multilevel modelling to investigate 
differences between the groups, and odds ratios along-
side 95% CIs will be reported. Multilevel modelling will 
allow for clustering of effect within a site and family nurse. 
Modelling the impact of key subgroups (deprivation; 
looked after status of mother; adaptive functioning; not 
in education, employment or training status; and age) 
and different intervention elements (eg, gestational age 
at programme entry, dosage) on outcome will be under-
taken by extending the primary models and testing for 
interaction effects. The role of potential moderators of 
programme effect (eg, domestic violence) will also be 
explored.
Secondary outcomes will assess group differences in 
objective and associated measures of maltreatment, inter-
mediate FNP programme outcomes as well as child health, 
development and educational outcomes (as detailed 
in table 2). The majority of these are binary outcomes 
(presence/absence of a status, meeting the key stage 
1 standard or not) and will be analysed using a multilevel 
logistic regression model. The distribution of potential 
continuous outcomes such as early-year assessment scores 
will be assessed before analysing using linear regression. 
Count data such as the number of attendances for injuries 
and ingestions will be analysed using a Poisson or nega-
tive binomial multilevel regression modelling. A detailed 
statistical plan will be written and signed off prior to any 
analysis.
A state transition model using Markov chains will 
be used to assess the probabilities of moving from one 
stage marker (states) to another.25 The transition prob-
abilities (the probability of the various state changes) in 
our model will be derived from our data and compared 
between groups.
Bias in the followed-up BB:2–6 sample will be quanti-
fied by examining group differences (participants and 
non-participants) in baseline variables such as age, depri-
vation, gestational age and education. Surveillance bias 
in detection of maltreatment during the child’s infancy 
and toddlerhood can be assessed by examining subse-
quent reporting.26 The duration between birth and the 
date of first referral to CSC will be calculated, and group 
differences will be examined using Cox regression anal-
ysis to calculate hazard ratios for referral, together with 
95% CIs. Surveillance bias is most likely to occur during 
the intervention phase, although improved handover to 
other services at 2 years may lead to higher identification 
in the following year. Severity of the referral will also be 
compared between the two groups (an approach used in 
US trials of NFP to explore surveillance bias).
Health economics
The economic evaluation will consider costs and conse-
quences of the FNP over the full follow-up period 
(BB:0–2 and BB:2–6). The current BB:0–2 study reported 
(1) a within-trial cost utility analysis assessing NHS costs 
against quality-adjusted life years (QALYs) from the 
perspective of the mother and (2) a within-trial cost–
consequences analysis relating all costs (including those 
to the social care, education and criminal justice sectors 
as well as health) against the full range of effects.12 
Cost-and-consequences framework is deemed the most 
appropriate economic evaluation framework for public 
health interventions27 and preferred by National Insti-
tute for Health and Care Excellence28 because it enables 
capture of equity consideration as well as intersectoral 
costs and consequences,29 yet applications are still 
limited.27
The absence of additional data on health-related 
quality of life within the BB:2-6 study means that it will 
not be possible to estimate QALYs beyond 24 months 
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post partum and hence extend the within-trial cost 
utility analysis. However, the within-trial cost–conse-
quences analysis will be extended from 0–2 to 0–6 years 
through collection of resource use data from medical 
and education records (including from the latter, data 
related to social care usage). Costs will be summarised 
against the range of outcomes collected within BB:2-6 
without aggregation to allow weighing up changes in the 
various outcomes reported in BB:2-6 against the changes 
in costs in a consistent and transparent manner.30 This 
will contribute to providing more robust and valid medi-
um-term estimates within the extended period.
ethIcs and dIsseMInatIon
legal and ethical considerations
The potential for using routine data in health and social 
care research has been greatly publicised, and study 
designs utilising these data are encouraged by funders.31 
There are, however, many inherent challenges in working 
with secondary-use data, in particular for this project the 
ethical and legal requirements/responsibilities, which 
have fundamentally informed this study design.
Although BB:0–2 linked trial data to HES and ONS data 
via NHS Digital, the governance requirements around the 
two applications have differed between the two studies 
not least because of the difference in consent models. 
Trial data were provided by NHS Digital and ONS after 
participant consent to prospective collection and for spec-
ified purposes limited to the time frame of that study. The 
current follow-on study uses a dissent model under which 
we are only able to send trial participant identifiers to ICs 
for matching to outcome data records if there is no objec-
tion received from mothers. This is especially important, 
as following an opportunity to object to being included 
in the current study, those women who withdrew from 
the original Building Blocks will be retained. The study 
will require all clinical, social and educational data to be 
held in a data safe haven using encrypted record identi-
fiers and analysis via a securely managed and monitored 
remote portal. The legal bases for transfer of identifiable 
data to ICs without explicit consent are as follows; s251 of 
the 2006 NHS Act 2006 for HES data from NHS Digital, 
s42(4) of the Statistics and Registration Service Act 2007 
through National Institute for Health Research funding 
for ONS data via NHS Digital and 6 (1) of Schedule 2 of 
the 1998 Data Protection Act for NPD data.
Dissemination of findings
The Building Blocks: 2–6 Study will generate policy-rele-
vant findings describing the medium-term impact of FNP 
on measurements of child maltreatment. The findings 
will also include other policy-relevant outcomes from the 
programme such as healthcare use, education attainment 
and changes in social care use over the 6 years of follow-up. 
Such medium-term evaluation remains important as some 
outcomes for the intervention are expected to arise only 
after the child’s second birthday, including maltreatment. 
This study will either confirm the largely negative trial 
findings from BB:0–2 further weakening the justification 
for FNP Programme continuation or provide a balance to 
the early measurable outcomes.
In addition to reporting the findings to the funder for 
this study, the funder for the BB:0–2 trial (DoH Policy 
Research Programme) will also be informed as well as the 
FNP National Unit. All local authorities in England will be 
notified of the results, as (since October 2015) they have 
responsibility for commissioning public health services 
for children aged 0–5. Participants will receive a summary 
of the results, and all reports and publications will be 
made publicly available in full on the Cardiff University 
website. The research team has previously convened and 
met twice with a stakeholder group, including relevant 
policy leads from each country in the UK delivering FNP 
(England, Scotland, Northern Ireland). We will stage a 
similar event to present and discuss the implications for 
practice and policy of the results of this medium-term 
follow-up of participants.
In addition to policy and public outputs, academic 
outputs will include (1) this protocol paper providing visi-
bility of this medium-term follow-up, (2) a methods paper 
describing the piloting process of the study (including 
data quality and success of data matching) and (3) main 
study findings. We aim to disseminate in high-quality, 
peer-reviewed journals and present in key conferences.
A particular benefit of this study is understanding of, 
and learning from, the governance challenges. There 
is potential to use this method for future trials looking 
at longer-term follow-up. Therefore, this study has the 
potential to add to the understanding of routine data and 
data linkage methods in future public health and clinical 
trials, and these planned publications will provide a basis 
for the dissemination of the success of these methods.
Finally, publishing protocol papers in medical jour-
nals was an important innovation for trials. They convey 
a number of benefits including transparency about what 
was intended by researchers and therefore comparison 
to what was actually reported. While protocols are more 
commonly published for trials, we consider that the 
protections afforded are similar for other study types. 
This may include inhibiting ‘data dredging’ and post-hoc 
revisions to original study plans. In our study, which links 
a trial cohort to routine data, we consider that this is espe-
cially important particularly because of the broad range 
of outcomes that are potentially impacted by this complex 
home-visiting intervention.
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